Gönül TEZEL, Mustafa AKÇAKUŞ, Nihal OYGÜR, Osman ÖZTEKİN, Salih KALAY, Murat ÇİFTÇİ

Yenidoğan Döneminde Supraventriküler Taşikardi ve Tedavi Yaklaşımları

Amaç: Prenatal ve postnatal dönemde supraventriküler taşikardi (SVT) tanısı alan yenidoğanların tedavi şekillerinin retrospektif olarak değerlendirilmesi.Gereç ve Yöntemler: SVT tanısı ile takip edilen 15 yenidoğan retrospektif olarak değerlendirildi. Hastalar SVT başlangıç zamanına göre prenatal başlangıçlı SVT (PreBSVT) ve postnatal başlangıçlı SVT (PostBSVT) olarak iki gruba ayrıldı.Bulgular: PreBSVT; 8 hastada (%53), PostBSVT; 7 hastada (%47) saptandı. Tüm hastalara atak sırasında ilk ilaç olarak intravenöz 0.1 mg/kg adenozin tedavisi verildiği, 4 hastada 4’lü antiaritmik (Adenozin, digoksin, amiadoron, Propranolol), 1 hastada 5’li antiaritmik (Adenozin, digoksini, amiadoron, Propranolol, Propafenon) kullanıldığı ve PreBSVT tanılı 2 hastaya ve PostBSVT tanılı 1 hastaya kardiyoversiyon uygulandığı görüldü.Sonuç: PreBSVT ve PostSVT tanılı hastalarda SVT’nin tedavi yaklaşımları ve sonuçları benzerdir.

Anahtar Kelimeler:

Supraventriküler taşikardi, Tedavi, Yenidoğan

Neonatal Period Supraventricular Tachycardia and Treatment Approaches in the

Objective: Retrospective analysis for treatment approaches of supraventricular tachycardia (SVT) during the prenatal and postnatal period.Material and Methods: Fifteen new-born patients who were followed with supraventricular tachycardia were analysed retrospectively. Patients were divided into two groups as prenatal onset (PreOSVT) and postnatal onset (PostOSVT).Results: Eight patients (53%) were diagnosed with PreOSVT and 7 patients (47%) were diagnosed with PostOSVT. It was observed that, 0.1 mg/kg dose of adenosine was used in all patient as a fi rst line treatment, 4 antiarrhythmic agents (amiodarone, propranolol, adenosine, digoxin) were used in 4 patients, 5 antiarrhythmic agents (amiodarone, propranolol, adenosine, digoxin, propafenone) were used in one patient and the cardioversion procedure was used in 2 patients with PreOSVT and one patient with PostOSVT.Conclusion: Treatment approaches and the results are similar in patients with PreOSVT and PostOSVT

Keywords:

Supraventricular tachycardia, Treatment, Newborn,

PDF

___

Van Hare GF. Neonatal arrhythmias. In: Fanaroff AA, Martin RJ (eds). Neonatal-Perinatal Medicine Diseases of the Fetus and Infant. Vol: 2, 9th ed. St. Louis: Mosby, 2011:1277-89.
Hoffman TM, Wernovsky G, Wieand TS, Cohen MI, Jennings AC, Vetter VL, et al. The incidence of arrhythmias in a pediatric intensive car e unit. Pediatr Cardiol 2002;23:598-604.
Tavera MC, Bassareo PP, Neroni P, Follese C, Manca D, Montis S, et al. Supraventricular tachycardia in neonates: Antiarrhythmic drug choice dilemma. J Matern Fetal Neonatal Med 2011;24:541- 4.
Garson A Jr, Gillette PC, McNamara DG. Supraventricular tachycardia in children: Clinical features, response to treatment, and long-term follow-up in 217 patients. J Pediatr 1981;98: 875-82.
Kleinman CS, Neghme RA. Cardiac arrhythmias in the human fetus. Pediatr Cardiol 2004;25:234-51.
Rasiah SV, Ewer AK, Miller P, Kilby MD. Prenatal diagnosis, management and outcome of fetal dysrhythmia: A tertiary fetal medicine centre experience over an eight-year period. Fetal Diagn Ther 2011;30:122-7.
Wren C. Cardiac arrhythmias in the fetus and newborn. Semin Fetal Neonatal Med 2006;11:182-90.
Oudijk MA, Visser GH, Meijboom EJ. Fetal tachyarrhythmia—part I: Diagnosis. Indian Pacing Electrophysiol J 2004;4:104-13.
Kantoch MJ. Supraventricular tachycardia in children. Indian J Pediatr 2005;72:609-19
Manole MD, Saladino RA. Emergency department management of the pediatric patient with supraventricular tachycardia. Pediatr Emerg Care 2007;23:176-85.
Balaguer Gargallo M, Jordán García I, Caritg Bosch J, Cambra Lasaosa FJ, Prada Hermogenes F, Palomaque Rico A. Supraventricular tachycardia in infants and children. An Pediatr 2007; 67:133-8.
Etheridge SP, Janet C, Steven J. Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants. Am Heart J 2001;141:105-10.
Abid L, Trabelsi I, Maazoun Y, Krichène S, Laroussi L, Hammami R, et al. Supraventricular tachycardia in infants. Ann Cardiol Angeiol 2011;60:141-7.
Park MK. Cardiac arrhytmias. In: Park MK (ed). Pediatric Cardiology for Practitioners. 5th ed. Philedelphia: Mosby Elsevier Pres, 2008: 417-44.
Bodegas A, Cabrera A, Sarrionaindia MJ, Idígoras G, Rumoroso JR, Pérez García P, et al. Propafenone effi cacy in preventing supraventricular tachycardia in childhood. Rev Esp Cardiol 1994;47:86-91.
Kishore AG, Camm AJ. Guidelines for the use of propafenone in treating supraventricular arrhythmias. Drugs 1995;50:250-62.
Stephanie BW, Wernovsky G. Arrhythmias. In: Cloherty John P, Eichenwald Eric C, Stark Ann R (eds). Manual of Neonatal Care, 6th ed. Philadelphia: Lippincott Williams and Wilkins, 2008:429- 35.